BURFORD CAPITAL LIMITED

Report Publication Announcement • Jan 9, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6543M

Burford Capital

09 January 2019

9 January 2019

NOTICE OF FULL YEAR 2018 RESULTS DISCLOSURE AND EARNINGS CALL DATE

Burford Capital Limited ("Burford" or "the Company"), the leading global finance and investment management firm focused on law, today announces that it will disclose its full year results for the twelve-month period ended 31 December 2018 on Wednesday 13 March 2019 at 7:00am (GMT).

Management will host an earnings call for investors and analysts at 2:00pm (GMT) / 10:00am (EDT) on Wednesday 13 March 2019.  Details of this call will be announced in due course.

For further information, please contact:

Burford Capital Limited
Elizabeth O'Connell, CFA, Chief Financial Officer	+1 212 235 6825
Macquarie Capital (Europe) Limited - NOMAD and Joint Broker	+44 (0)20 3037 2000
Jonny Allison
Nicholas Harland
Liberum Capital Limited - Joint Broker	+44 (0)20 3100 2222
Richard Crawley
Jamie Richards
Numis Securities Limited - Joint Broker	+44 (0)20 7260 1000
Charlie Farquhar
Jonathan Abbott
Montfort Communications Limited - Financial Communications	+44 (0)20 3770 7908
Robert Bailhache - email

About Burford Capital

Burford Capital is the leading global finance and investment management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London, Chicago, Washington DC, Singapore and Sydney.

For more information about Burford: www.burfordcapital.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NORSSSFDUFUSEDF